rs113080067
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001256573.2(CHRNA4):c.-322C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00018 in 1,612,656 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001256573.2 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHRNA4 | NM_000744.7 | c.225C>T | p.Asp75Asp | synonymous_variant | Exon 2 of 6 | ENST00000370263.9 | NP_000735.1 | |
CHRNA4 | NM_001256573.2 | c.-322C>T | 5_prime_UTR_premature_start_codon_gain_variant | Exon 2 of 6 | NP_001243502.1 | |||
CHRNA4 | NM_001256573.2 | c.-322C>T | 5_prime_UTR_variant | Exon 2 of 6 | NP_001243502.1 | |||
CHRNA4 | NR_046317.2 | n.409C>T | non_coding_transcript_exon_variant | Exon 2 of 6 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000466 AC: 71AN: 152222Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000164 AC: 41AN: 249774Hom.: 0 AF XY: 0.000147 AC XY: 20AN XY: 135614
GnomAD4 exome AF: 0.000149 AC: 218AN: 1460316Hom.: 0 Cov.: 38 AF XY: 0.000157 AC XY: 114AN XY: 726446
GnomAD4 genome AF: 0.000479 AC: 73AN: 152340Hom.: 0 Cov.: 34 AF XY: 0.000483 AC XY: 36AN XY: 74500
ClinVar
Submissions by phenotype
not provided Benign:3
- -
- -
CHRNA4: BS1, BS2 -
Autosomal dominant nocturnal frontal lobe epilepsy Benign:1
- -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at